{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:28:14Z","timestamp":1772162894140,"version":"3.50.1"},"reference-count":29,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100011095","name":"BD Biosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2021,11,18]]},"abstract":"<jats:p>Nucleic acid amplification testing (NAAT) for SARS-CoV-2 is the standard approach for confirming COVID-19 cases. This study compared results between two emergency use authorization (EUA) NAATs, with two additional EUA NAATs utilized for discrepant testing.<\/jats:p>","DOI":"10.1128\/jcm.01019-21","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T14:29:28Z","timestamp":1632925768000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":4,"title":["Performance Evaluation of the BD SARS-CoV-2 Reagents for the BD MAX System"],"prefix":"10.1128","volume":"59","author":[{"given":"Karen","family":"Yanson","sequence":"first","affiliation":[{"name":"Becton, Dickinson and Company, BD Life Sciences\u2014Integrated Diagnostic Solutions, Sparks, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Laviers","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company, BD Life Sciences\u2014Integrated Diagnostic Solutions, Sparks, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Neely","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company, BD Life Sciences\u2014Integrated Diagnostic Solutions, Sparks, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Lockamy","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company, BD Life Sciences\u2014Integrated Diagnostic Solutions, Sparks, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Carlos","family":"Castillo-Hernandez","sequence":"additional","affiliation":[{"name":"CTMD Research, Palm Springs, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Oldfied","sequence":"additional","affiliation":[{"name":"Fellows Research Alliance, Inc., Savannah, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Ackerman","sequence":"additional","affiliation":[{"name":"Comprehensive Clinical Research, LLC, West Palm, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Ackerman","sequence":"additional","affiliation":[{"name":"Comprehensive Clinical Research, LLC, West Palm, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6100-1822","authenticated-orcid":true,"given":"Daniel A.","family":"Ortiz","sequence":"additional","affiliation":[{"name":"William Beaumont Hospital, Royal Oak, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sixto","family":"Pacheco","sequence":"additional","affiliation":[{"name":"BioCollections Worldwide, Inc., Miami, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6134-151X","authenticated-orcid":true,"given":"Patricia J.","family":"Simner","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine, Department of Pathology, Division of Medical Microbiology, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Young","sequence":"additional","affiliation":[{"name":"Tricore Reference Laboratory, Albuquerque, New Mexico, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"McElvania","sequence":"additional","affiliation":[{"name":"NorthShore University Health System, Department of Pathology and Laboratory Medicine, Evanston, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles K.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company, BD Life Sciences\u2014Integrated Diagnostic Solutions, Sparks, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017"},{"key":"e_1_3_3_3_2","unstructured":"Johns Hopkins University and Medicine. 2020. Mortality analyses. Coronavirus Resource Center. https:\/\/coronavirus.jhu.edu\/data\/mortality."},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2607.200282"},{"key":"e_1_3_3_5_2","unstructured":"Centers for Disease Control and Prevention. 2020. Prioritizing COVID-19 contact tracing mathematical modeling methods and findings. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/php\/contact-tracing\/contact-tracing-plan\/prioritization\/mathematicalmodeling.html. Accessed 23 February 2021."},{"key":"e_1_3_3_6_2","unstructured":"World Health Organization Global Research Collaboration for Infectious Disease Preparedness. 2020. COVID 19: public health emergency of international concern (PHEIC). Global research and innovation forum: towards a research roadmap. 02\/11\/2020\u201302\/12\/2020 World Health Organization Geneva Switzerland. https:\/\/www.who.int\/blueprint\/priority-diseases\/key-action\/Global_Research_Forum_FINAL_VERSION_for_web_14_feb_2020.pdf."},{"key":"e_1_3_3_7_2","unstructured":"U.S. Food and Drug Administration. Coronavirus disease 2019 (COVID-19) emergency use authorization for medical devices. U.S. Food and Drug Administration Washington DC. https:\/\/www.fda.gov\/medical-devices\/emergency-use-authorizations-medical-devices\/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices. Accessed 23 February 2021."},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/M20-1301"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2020.06.001"},{"key":"e_1_3_3_10_2","unstructured":"Centers for Disease Control and Prevention. Interim guidelines for collecting handling and testing clinical specimens for COVID-19. Accessed 24 February 2021. https:\/\/www.cdc.gov\/coronavirus\/2019-nCoV\/lab\/guidelines-clinical-specimens.html."},{"key":"e_1_3_3_11_2","unstructured":"Becton Dickinson and Company. 2020. BD SARS-CoV-2 Reagents for BD MAX system package insert. Becton Dickinson and Company Sparks MD."},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2021.115334"},{"key":"e_1_3_3_13_2","unstructured":"U.S. Food and Drug Administration. 2021. False positive results with BD SARS-CoV-2 reagents for the BD Max system: letter to clinical laboratory staff and health care providers. https:\/\/www.fda.gov\/medical-devices\/letters-health-care-providers\/false-positive-results-bd-sars-cov-2-reagents-bd-max-system-letter-clinical-laboratory-staff-and."},{"key":"e_1_3_3_14_2","unstructured":"U.S. Food and Drug Administration. 2021. BD SARS-CoV-2 reagents for BD MAX system: letter of authorization. https:\/\/www.fda.gov\/media\/136813."},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2015151516"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1101\/gr.3.3.s18"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2021.114182"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104501"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01535-20"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2020.113970"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01134-20"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2020.115260"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.04.011"},{"key":"e_1_3_3_24_2","unstructured":"Roche Diagnostics. 2020. Roche Cobas SARS-CoV-2 qualitative assay for use on the cobas 6800\/8800 systems package insert. Roche Diagnostics Indianapolis IN."},{"key":"e_1_3_3_25_2","unstructured":"Hologic. 2020. Hologic Aptima SARS-CoV-2 assay (Panther system) package insert. Hologic Marlborough MA."},{"key":"e_1_3_3_26_2","unstructured":"Biomerieux. 2020. Biomerieux BioFire respiratory panel 2.1 (RP2.1) package insert. Biomerieux BioFire Diagnostics Salt Lake City UT."},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/s10038-020-0808-9"},{"key":"e_1_3_3_28_2","unstructured":"Centers for Disease Control and Prevention. SARS-CoV-2 variant classifications and definitions. Centers for Disease Control and Prevention Atlanta GA. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/variants\/variant-info.html. Accessed 1 April 2021."},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-0761-6"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.20.253591"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.01019-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.01019-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T08:07:01Z","timestamp":1646467621000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.01019-21"}},"subtitle":[],"editor":[{"given":"Melissa B.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,11,18]]}},"alternative-id":["10.1128\/JCM.01019-21"],"URL":"https:\/\/doi.org\/10.1128\/jcm.01019-21","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.05.12.21257120","asserted-by":"object"}]},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]},"assertion":[{"value":"2021-05-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01019-21"}}